Vivolta, a Waalre, The Netherlands-based company which specializes in the development and manufacturing of electrospun medical products, raised €7M in funding.
The round saw participation from existing shareholders and the Dutch government’s NXTGEN HIGHTECH growth fund. Shareholders also include TIIN Capital, Lumana Invest, Borski Fund, and Brabantse Ontwikkelings Maatschappij.
The company intends to use the funds for further expansion of its client-centric services, particularly in the areas of application development, engineering, commercial support, quality, regulatory, and manufacturing, of its ISO class 7 production area footprint, and of its proprietary MediSpin production platform.
Led by CEO Ramon Solberg, Vivolta specializes in the development and manufacturing of electrospun medical products. Utilizing its proprietary, fully automated MediSpin production platform, the company supports its clients in realizing electrospun medical solutions that guide the body to heal itself. These medical products restore and cure damaged and diseased tissues, with the aim of improving patients’ lives while minimizing complications. The solutions are applicable to a broad array of therapeutic areas with unmet clinical need, such as cardiovascular implants, soft tissue repair, orthopaedic sports medicine, and drug delivery.
FinSMEs
13/06/2023